[ Pobierz całość w formacie PDF ]
.Virology 288(1):8 17.Glass WG, Chen BP, Liu MT, Lane TE.2002.Mouse hepatitis virus infection of the central nerv-ous system: chemokine-mediated regulation of host defense and disease.Viral Immunol15(2):261 272.Glass WG, Hickey MJ, Hardison JL, Liu MT, Manning JE, Lane TE.2004.Antibody targeting ofthe CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervoussystem and reduced neurologic disease in a viral model of multiple sclerosis.J Immunol172(7):4018 4025.Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, Murphy PM.2005.Chemokine receptorCCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection.J Exp Med 202(8):1087 1098.Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, Frank WA, Pape J, Cheshier RC, MurphyPM.2006.CCR5 deficiency increases risk of symptomatic West Nile virus infection.J ExpMed 203(1):35 40.Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, Lindberg FP.2000.Survival ofStaphylococcus aureus inside neutrophils contributes to infection.J Immunol 164(7):3713 3722.Griffin DD, Bellini WJ.1996.Measles virus.In Fields Virology.3rd edition.Vol.1, eds.BN Fields,DM Knipe, PM Howley, pp.1267 1312.Philadelphia, PA: Lippincott-Raven Publishers. Chemokines and Microbial Infection of the Central Nervous System 257Grossman Z, Meier-Schellersheim M, Paul WE, Picker LJ.2006.Pathogenesis of HIV infection:what the virus spares is as important as what it destroys.Nat Med 12(3):289 295.Grygorczuk S, Pancewicz S, Kondrusik M, Swierzbinska R, Zajkowska J, Hermanowska-Szpakowicz T.2003.[Serum and cerebrospinal fluid concentration of inflammatory proteins MIP-1-alpha andMIP-1-beta and of interleukin 8 in the course of borreliosis].Neurol Neurochir Pol 37(1):73 87.Halstensen A, Ceska M, Brandtzaeg P, Redl H, Naess A, Waage A.1993.Interleukin-8 in serum andcerebrospinal fluid from patients with meningococcal disease.J Infect Dis 167(2):471 475.Hausler KG, Prinz M, Nolte C, Weber JR, Schumann RR, Kettenmann H, Hanisch UK.2002.Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopol-ysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages.EurJ Neurosci 16(11):2113 2122.Hemmer B, Gran B, Zhao Y, Marques A, Pascal J, Tzou A, Kondo T, Cortese I, Bielekova B,Straus SE and others.1999.Identification of candidate T-cell epitopes and molecular mimicsin chronic Lyme disease.Nat Med 5(12):1375 1382.Hickey M.J., Held K.S., Baum E., Gao J.L., Murphy P.M., Lau T.E.2007.CCR5 deficiency increases sus-ceptibility to fatal corona virus infection of the central nervous system.Viral Immunology, In press.Hoffman LM, Fife BT, Begolka WS, Miller SD, Karpus WJ.1999.Central nervous system chemokineexpression during Theiler s virus-induced demyelinating disease.J Neurovirol 5(6):635 42.Hofman FM, Hinton DR, Baemayr J, Weil M, Merrill JE.1991.Lymphokines and immunoregulatorymolecules in subacute sclerosing panencephalitis.Clin Immunol Immunopathol 58(3):331 342.Holmes KV.2003.SARS-associated coronavirus.N Engl J Med 348(20):1948 1951.Holmes K, Lai M.1996.Coronaviridae and their replication.In Fields Virology.3rd edition.Vol.1,eds.BN Fields, DM Knipe, PM Howley, pp.1075 1094.Philadelphia, PA: Lippincott-RavenPublishers.Inaba Y, Ishiguro A, Shimbo T.1997.The production of macrophage inflammatory protein-1alpha inthe cerebrospinal fluid at the initial stage of meningitis in children.Pediatr Res 42(6):788 793.Jacobsen M, Zhou D, Cepok S, Nessler S, Happel M, Stei S, Wilske B, Sommer N, Hemmer B.2003.Clonal accumulation of activated CD8 + T cells in the central nervous system during theearly phase of neuroborreliosis.J Infect Dis 187(6):963 973.Jahrling PB, Peters CJ.1992.Lymphocytic choriomeningitis virus.A neglected pathogen of man.Arch Pathol Lab Med 116(5):486 488.Janssen R, Cornblath D, Epstein L, Foa R, McArthur J, Price R, Asbury A, Beckett A, Benson D,Bridge T.1991.Nomenclature and research case definitions for neurologic manifestations ofhuman immunodeficiency virus-type 1 (HIV-1) infection.Report of a Working Group of theAmerican Academy of Neurology AIDS Task Force.Neurology 41(6):778 785.Kastenbauer S, Angele B, Sporer B, Pfister HW, Koedel U.2005.Patterns of protein expression in infec-tious meningitis: a cerebrospinal fluid protein array analysis.J Neuroimmunol 164(1 2):134 139.Katz M.1995.Clinical spectrum of measles.Curr Top Microbiol Immunol 191:1 12.Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA.2005.HIV-1 infection and AIDS: con-sequences for the central nervous system.Cell Death Differ 12 Suppl 1:878 892.Kielian T.2004a.Immunopathogenesis of brain abscess.J Neuroinflammation 1(1):16.Kielian T.2004b.Microglia and chemokines in infectious diseases of the nervous system: viewsand reviews.Front Biosci 9:732 750.Kielian T, Barry B, Hickey WF.2001.CXC chemokine receptor-2 ligands are required for neu-trophil-mediated host defense in experimental brain abscesses.J Immunol 166(7):4634 4643.Kielian T, Mayes P, Kielian M.2002.Characterization of microglial responses to Staphylococcusaureus: effects on cytokine, costimulatory molecule, and Toll-like receptor expression.J Neuroimmunol 130(1 2):86 99.Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA, Engle M, Diamond MS.2005.Neuronal CXCL10 directs CD8 + T-cell recruitment and control of West Nile virus encepha-litis.J Virol 79(17):11457 11466.Koedel U, Rupprecht T, Angele B, Heesemann J, Wagner H, Pfister HW, Kirschning CJ.2004.MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniaein the CNS.Brain 127(Pt 6):1437 1445. 258 M.J.Hickey et al.Koedel U, Scheld WM, Pfister HW.2002.Pathogenesis and pathophysiology of pneumococcalmeningitis.Lancet Infect Dis 2(12):721 736.Kornelisse RF, Hazelzet JA, Hop WC, Spanjaard L, Suur MH, van der Voort E, de Groot R.1997.Meningococcal septic shock in children: clinical and laboratory features, outcome, and devel-opment of a prognostic score.Clin Infect Dis 25(3):640 646.Lahrtz F, Piali L, Spanaus KS, Seebach J, Fontana A.1998.Chemokines and chemotaxis ofleukocytes in infectious meningitis.J Neuroimmunol 85(1):33 43.Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ.1998.Dynamic regula-tion of alpha- and beta-chemokine expression in the central nervous system during mousehepatitis virus-induced demyelinating disease.J Immunol 160(2):970 978.Lane TE, Hardison JL, Walsh KB.2006.Functional diversity of chemokines and chemokinereceptors in response to viral infection of the central nervous system.Curr Top MicrobiolImmunol 303:1 27.Le Y, Zhou Y, Iribarren P, Wang J.2004.Chemokines and chemokine receptors: their manifoldroles in homeostasis and disease.Cell Mol Immunol 1(2):95 104.Lim JK, Glass WG, McDermott DH, Murphy PM.2006.CCR5: no longer a good for nothing gene chemokine control of West Nile virus infection.Trends Immunol 27(7):308 312.Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, Lane TE.2000.TheT cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease.J Immunol 165(5):2327 2330 [ Pobierz całość w formacie PDF ]
zanotowane.pl doc.pisz.pl pdf.pisz.pl matkasanepid.xlx.pl
.Virology 288(1):8 17.Glass WG, Chen BP, Liu MT, Lane TE.2002.Mouse hepatitis virus infection of the central nerv-ous system: chemokine-mediated regulation of host defense and disease.Viral Immunol15(2):261 272.Glass WG, Hickey MJ, Hardison JL, Liu MT, Manning JE, Lane TE.2004.Antibody targeting ofthe CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervoussystem and reduced neurologic disease in a viral model of multiple sclerosis.J Immunol172(7):4018 4025.Glass WG, Lim JK, Cholera R, Pletnev AG, Gao JL, Murphy PM.2005.Chemokine receptorCCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection.J Exp Med 202(8):1087 1098.Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, Frank WA, Pape J, Cheshier RC, MurphyPM.2006.CCR5 deficiency increases risk of symptomatic West Nile virus infection.J ExpMed 203(1):35 40.Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, Lindberg FP.2000.Survival ofStaphylococcus aureus inside neutrophils contributes to infection.J Immunol 164(7):3713 3722.Griffin DD, Bellini WJ.1996.Measles virus.In Fields Virology.3rd edition.Vol.1, eds.BN Fields,DM Knipe, PM Howley, pp.1267 1312.Philadelphia, PA: Lippincott-Raven Publishers. Chemokines and Microbial Infection of the Central Nervous System 257Grossman Z, Meier-Schellersheim M, Paul WE, Picker LJ.2006.Pathogenesis of HIV infection:what the virus spares is as important as what it destroys.Nat Med 12(3):289 295.Grygorczuk S, Pancewicz S, Kondrusik M, Swierzbinska R, Zajkowska J, Hermanowska-Szpakowicz T.2003.[Serum and cerebrospinal fluid concentration of inflammatory proteins MIP-1-alpha andMIP-1-beta and of interleukin 8 in the course of borreliosis].Neurol Neurochir Pol 37(1):73 87.Halstensen A, Ceska M, Brandtzaeg P, Redl H, Naess A, Waage A.1993.Interleukin-8 in serum andcerebrospinal fluid from patients with meningococcal disease.J Infect Dis 167(2):471 475.Hausler KG, Prinz M, Nolte C, Weber JR, Schumann RR, Kettenmann H, Hanisch UK.2002.Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopol-ysaccharide- and pneumococcal cell wall-stimulated mouse microglia and macrophages.EurJ Neurosci 16(11):2113 2122.Hemmer B, Gran B, Zhao Y, Marques A, Pascal J, Tzou A, Kondo T, Cortese I, Bielekova B,Straus SE and others.1999.Identification of candidate T-cell epitopes and molecular mimicsin chronic Lyme disease.Nat Med 5(12):1375 1382.Hickey M.J., Held K.S., Baum E., Gao J.L., Murphy P.M., Lau T.E.2007.CCR5 deficiency increases sus-ceptibility to fatal corona virus infection of the central nervous system.Viral Immunology, In press.Hoffman LM, Fife BT, Begolka WS, Miller SD, Karpus WJ.1999.Central nervous system chemokineexpression during Theiler s virus-induced demyelinating disease.J Neurovirol 5(6):635 42.Hofman FM, Hinton DR, Baemayr J, Weil M, Merrill JE.1991.Lymphokines and immunoregulatorymolecules in subacute sclerosing panencephalitis.Clin Immunol Immunopathol 58(3):331 342.Holmes KV.2003.SARS-associated coronavirus.N Engl J Med 348(20):1948 1951.Holmes K, Lai M.1996.Coronaviridae and their replication.In Fields Virology.3rd edition.Vol.1,eds.BN Fields, DM Knipe, PM Howley, pp.1075 1094.Philadelphia, PA: Lippincott-RavenPublishers.Inaba Y, Ishiguro A, Shimbo T.1997.The production of macrophage inflammatory protein-1alpha inthe cerebrospinal fluid at the initial stage of meningitis in children.Pediatr Res 42(6):788 793.Jacobsen M, Zhou D, Cepok S, Nessler S, Happel M, Stei S, Wilske B, Sommer N, Hemmer B.2003.Clonal accumulation of activated CD8 + T cells in the central nervous system during theearly phase of neuroborreliosis.J Infect Dis 187(6):963 973.Jahrling PB, Peters CJ.1992.Lymphocytic choriomeningitis virus.A neglected pathogen of man.Arch Pathol Lab Med 116(5):486 488.Janssen R, Cornblath D, Epstein L, Foa R, McArthur J, Price R, Asbury A, Beckett A, Benson D,Bridge T.1991.Nomenclature and research case definitions for neurologic manifestations ofhuman immunodeficiency virus-type 1 (HIV-1) infection.Report of a Working Group of theAmerican Academy of Neurology AIDS Task Force.Neurology 41(6):778 785.Kastenbauer S, Angele B, Sporer B, Pfister HW, Koedel U.2005.Patterns of protein expression in infec-tious meningitis: a cerebrospinal fluid protein array analysis.J Neuroimmunol 164(1 2):134 139.Katz M.1995.Clinical spectrum of measles.Curr Top Microbiol Immunol 191:1 12.Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA.2005.HIV-1 infection and AIDS: con-sequences for the central nervous system.Cell Death Differ 12 Suppl 1:878 892.Kielian T.2004a.Immunopathogenesis of brain abscess.J Neuroinflammation 1(1):16.Kielian T.2004b.Microglia and chemokines in infectious diseases of the nervous system: viewsand reviews.Front Biosci 9:732 750.Kielian T, Barry B, Hickey WF.2001.CXC chemokine receptor-2 ligands are required for neu-trophil-mediated host defense in experimental brain abscesses.J Immunol 166(7):4634 4643.Kielian T, Mayes P, Kielian M.2002.Characterization of microglial responses to Staphylococcusaureus: effects on cytokine, costimulatory molecule, and Toll-like receptor expression.J Neuroimmunol 130(1 2):86 99.Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA, Engle M, Diamond MS.2005.Neuronal CXCL10 directs CD8 + T-cell recruitment and control of West Nile virus encepha-litis.J Virol 79(17):11457 11466.Koedel U, Rupprecht T, Angele B, Heesemann J, Wagner H, Pfister HW, Kirschning CJ.2004.MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniaein the CNS.Brain 127(Pt 6):1437 1445. 258 M.J.Hickey et al.Koedel U, Scheld WM, Pfister HW.2002.Pathogenesis and pathophysiology of pneumococcalmeningitis.Lancet Infect Dis 2(12):721 736.Kornelisse RF, Hazelzet JA, Hop WC, Spanjaard L, Suur MH, van der Voort E, de Groot R.1997.Meningococcal septic shock in children: clinical and laboratory features, outcome, and devel-opment of a prognostic score.Clin Infect Dis 25(3):640 646.Lahrtz F, Piali L, Spanaus KS, Seebach J, Fontana A.1998.Chemokines and chemotaxis ofleukocytes in infectious meningitis.J Neuroimmunol 85(1):33 43.Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ.1998.Dynamic regula-tion of alpha- and beta-chemokine expression in the central nervous system during mousehepatitis virus-induced demyelinating disease.J Immunol 160(2):970 978.Lane TE, Hardison JL, Walsh KB.2006.Functional diversity of chemokines and chemokinereceptors in response to viral infection of the central nervous system.Curr Top MicrobiolImmunol 303:1 27.Le Y, Zhou Y, Iribarren P, Wang J.2004.Chemokines and chemokine receptors: their manifoldroles in homeostasis and disease.Cell Mol Immunol 1(2):95 104.Lim JK, Glass WG, McDermott DH, Murphy PM.2006.CCR5: no longer a good for nothing gene chemokine control of West Nile virus infection.Trends Immunol 27(7):308 312.Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, Lane TE.2000.TheT cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease.J Immunol 165(5):2327 2330 [ Pobierz całość w formacie PDF ]